Rizatriptan Tablet Versus Wafer: Patient Preference
- 1 May 2000
- journal article
- research article
- Published by Wiley in Headache: The Journal of Head and Face Pain
- Vol. 40 (5) , 371-372
- https://doi.org/10.1046/j.1526-4610.2000.00055.x
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Efficacy and Safety of Rizatriptan Wafer for the Acute Treatment of MigraineCephalalgia, 1999
- 41st Annual Scientific Meeting The American Association for the Study of Headache June 1l-13, 1999, Boston, MassachusettsHeadache: The Journal of Head and Face Pain, 1999
- Oral Rizatriptan Versus Oral Sumatriptan: A Direct Comparative Study in the Acute Treatment of MigraineHeadache: The Journal of Head and Face Pain, 1998
- Crossover Comparison of Rizatriptan 5 mg and 10 mg Versus Sumatriptan 25 mg and 50 mg in MigraineHeadache: The Journal of Head and Face Pain, 1998
- A placebo-controlled crossover study of rizatriptan in the treatment of multiple migraine attacksNeurology, 1998
- Rizatriptan (MAXALT) for the Acute Treatment of Migraine and Migraine Recurrence. A Placebo‐Controlled, Outpatient StudyHeadache: The Journal of Head and Face Pain, 1998